Acidic spore-based probiotic composition
A heat-treated acidic beverage with Bacillus subtilis spores addresses the viability challenge in probiotic beverages, ensuring high survival rates and effective probiotic delivery at room temperature, enhancing shelf life and reducing energy use.
Patent Information
- Application Number
- JP2026525547
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-10-30
- Filing Date
- 2024-10-24
- Publication Date
- 2026-11-19
AI Technical Summary
Existing acidic probiotic beverages face challenges in maintaining the viability of probiotic strains during heat treatment required for sterilization, leading to poor survival rates and ineffective health benefits due to varying pH and temperature conditions.
A heat-treated acidic beverage containing viable Bacillus subtilis spores is developed, which survives low pH and high temperature environments, allowing for shelf-stable storage at room temperature without refrigeration.
The method ensures at least 70% viability of Bacillus subtilis spores post-heat treatment, providing a stable and effective probiotic beverage that can be stored and consumed without refrigeration, reducing energy consumption and manufacturing costs.
Smart Images

Figure 2026539077000001 
Figure 2026539077000002 
Figure 2026539077000003
Abstract
Description
[Technical Field]
[0001] The present invention relates to the field of spore-based probiotic compositions. A heat-treated acidic spore-based probiotic composition is provided, comprising multiple viable probiotic microorganisms having biological or therapeutic activity in the gastrointestinal tract. A method for producing the heat-treated acidic spore-based probiotic composition is also provided. [Background technology]
[0002] Probiotics are increasingly recognized as playing an important and beneficial role in human health, particularly in restoring or improving the composition of the gut microbiota.
[0003] Probiotics are typically offered as dietary supplements, often in capsule and powder form. However, liquid media are a preferred method of delivering probiotics because they can improve absorption and distribution throughout the digestive tract. Furthermore, liquid media are convenient and eliminate the need to swallow pills or tablets. Probiotics can also be found in beverages, but such beverages usually require refrigerated transport, refrigerated storage, and refrigerated use to maintain the activity / viability of the probiotics, resulting in a limited shelf life.
[0004] Acidic beverages, including most juices, teas, sodas, and sports drinks, are enjoyed by many consumers worldwide. While some acids, such as citric acid in citrus drinks, occur naturally, adding acids to beverages can provide a sour and pungent taste that balances the sweetness of the sugars present, and they are also known to function as preservatives. Many acidic beverages do not require refrigeration and have a shelf life of several months.
[0005] With growing interest in probiotics and consumers seeking a convenient way to regularly incorporate them into their diets, acidic beverages containing probiotics that can be stored at room temperature and consumed straight from the container seem like a natural choice. However, such beverages face challenges. To be considered safe and shelf-stable, acidic beverages must be sterilized or pasteurized, which are typically provided as heat treatments. However, most probiotic strains, even those that can be supplied as spores, have poor survival rates in the low pH, high temperature environment required to sterilize acidic beverages. As a result, many commercially available acidic probiotic beverages do not meet the efficacy claims on their labels in terms of the number and variety of viable microorganisms present in the product, and do not deliver the amount necessary for consumption for health benefits.
[0006] U.S. Patent No. 10494684B2 relates to a strain of Bacillus subtilis identified as MB40 (deposited under ATCC accession number PTA-122264). Example 2 evaluated the viability of MB40 immersed in a hot tea preparation made from store-bought Orange Pekoe and Pekoe Cut Black Tea teabags. After immersing the MB40-containing teabags in boiling water (100°C) for 4 minutes, a total place count (TPC) viability of 84% was reported. However, Example 2 does not describe the pH of the tea preparation, which can vary considerably depending on, for example, the immersion time, the brand / mixture of tea, and the ratio of tea to water used to brew the tea preparation. In another example, identified as Example 12 of U.S. Patent No. 1,0494,684,B2, the viability of MB40 was tested over 10 months at various pH levels (pH 2, 4, and 6) and solid percentage levels (solids made from various amounts of sugar and pea protein), and the results were concluded to explain that MB40 exhibits good viability at a wide range of solid percentage levels within the pH range of 4 to 6.
[0007] International Publication No. 2023 / 196003A1 concerns a strain of Bacillus subtilis identified as BS50 (deposited under ATCC accession number PTA-127287). In Example 4, the stability of BS50 in a hot beverage matrix was tested using store-bought Pekoe Cut Black Tea tea bags, concluding that while BS50 spore survival decreased with increasing immersion temperature, at least 50% of spores survived immersion temperatures up to 100°C. A similar experiment added BS50 to ground coffee, brewed the resulting mixture, and reported 100% survival of BS50. However, this example does not describe the actual pH of the tea preparation and the brewed coffee, which can vary considerably. [Overview of the Initiative] [Means for solving the problem]
[0008] This invention is based on the remarkable inventive discovery that a strain of Bacillus subtilis, known to be a probiotic microorganism, can survive heat treatment in an acidic environment. Such a probiotic Bacillus subtilis strain can be supplied to an acidic beverage, which is then heat-sterilized or pasteurized to improve its shelf life. The resulting room-temperature storable acidic probiotic beverage does not require refrigeration, and therefore the production, packaging, transportation, and storage of the beverage are significantly less energy-intensive.
[0009] The present invention provides a heat-treated acidic beverage containing viable spores of Bacillus subtilis and a method for producing such a heat-treated acidic beverage. [Brief explanation of the drawing]
[0010] [Figure 1]This shows the survival of endospores of Bacillus probiotic strains in acidic solution at 0 and 7 days after heat treatment. CTRL = no pasteurization, i.e., no heat or pH change; HU58 = Bacillus subtilis HU58 (trademark); DE111 = Bacillus subtilis DE111 (registered trademark); BC30 = B. coagulans BC30 (trademark). [Modes for carrying out the invention]
[0011] Definition: Where used herein, the verb “includes” and its conjugations as used in this specification and claims are used in a non-restrictive sense to mean that the item following the word is included, but not that any item not specifically mentioned is excluded. In addition, references to elements with the indefinite article “a” or “an” do not exclude the possibility of two or more elements being present unless the context explicitly requires that there be one or only one element. Thus, the indefinite article “a” or “an” usually means “at least one.”
[0012] Unless otherwise defined or explicitly indicated by context, all percentages are weight percentages (percent w / w or "%(w / w)"). The term "%(w / v)" refers to the concentration of a substance in a solution and is expressed as a weight percentage per unit volume.
[0013] References to values or parameters with "approximately" in this specification include aspects relating to the value or parameter itself. For example, a statement referring to "approximately X" includes aspects relating to "X". When used in conjunction with a measured value, "approximately" includes a range that encompasses at least the uncertainty associated with the method of measuring a particular value, and may include a range of plus or minus two standard deviations around the stated value.
[0014] The drawings are intended to illustrate, and should not be considered as limiting, specific convenient embodiments of the present invention.
[0015] Furthermore, naturally, embodiments described in relation to one of the embodiments described herein may be equally applicable to other embodiments unless otherwise specified.
[0016] Unless otherwise defined or explicitly indicated by the context, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art to which this invention pertains.
[0017] Bacterial count: The terms “bacterial count” and “bacterial mass” are used interchangeably and have their usual meanings as are well known and understood to those skilled in the art. In relation to the present invention, bacterial count is given as a measurement of viable bacterial colony-forming units per gram or per milliliter, abbreviated as CFU / g and CFU / ml, respectively. Bacterial count may be determined by any method known to those skilled in the art, for example, by viable bacterial colony-forming units (CFU), quantitative polymerase chain reaction (qPCR), flow cytometry, live-dead staining, propidium monoazide qPCR (PMA-qPCR), microscopy, metabolic assay, spectrophotometrics, or any combination thereof, but not limited to the following. Methods for determining bacterial count, such as those disclosed herein, are common and will be apparent to those skilled in the art.
[0018] Colony: The term “colony” means a visible cluster or group of microbial cells when used in reference to “clones,” “isolated,” or “cells.” Colonies can be grown and obtained in solid media such as agar.
[0019] Composition: In relation to the present invention, the term "composition" encompasses any type of composition containing the Bacillus subtilis spores of the present invention. In relation to the present invention, a composition may be a liquid composition or a dry composition.
[0020] Derived from: In relation to the present invention, “derived from” means that the Bacillus subtilis spores used in accordance with the present invention are derived from the source sample. As used herein, “derived from” is interchangeable with the terms “originating from” and “obtained,” and refers to the source from which the spores are obtained. In some embodiments, the source sample includes a strain of Bacillus subtilis known to be found in, constitute within, or inhabit within an environmental niche and / or microbiome niche. In relation to the present invention, the microbiome is the genetic material of all microorganisms (bacteria, fungi, protists and viruses) that inhabit or reside in the human body.
[0021] Effective dose: As used herein, “effective dose” is defined as the amount effective in achieving a desired biological outcome, such as the alleviation, prevention, or treatment of a disease or condition and / or induction of a particular beneficial effect. In some embodiments, the effective dose is the amount supplied in a single serving of probiotic beverage, in which case consumption of multiple servings over time is required for the beneficial effect to be observed.
[0022] Isolated: The term “isolated” means that one or more microorganisms, such as bacterial strains described herein, are in a form or environment that does not occur in nature; that is, one or more microorganisms have been at least partially removed from one or more or all of the natural components to which they are naturally bound.
[0023] Probiotics: In relation to the present invention, the term “probiotics” refers to microorganisms that, when consumed, may have beneficial effects on the health of a subject, for example, the health of a human subject. Typically, probiotics are generally defined as “live microorganisms that, when administered in appropriate amounts, confer health benefits to a host,” where health benefits include, for example, restoring or improving the composition of the gut microbiota. See, for example, FAO / WHO, Guidelines for the evaluation of probiotics in food, London, Ontario, Canada (2002), which is incorporated herein by reference in its entirety. Thus, the acidic probiotic beverage obtained by the method of the present invention may, when ingested, have beneficial effects on the health of a subject, for example, a human subject.
[0024] Probiotic beverage: In relation to the present invention, “probiotic beverage” comprises at least a probiotic composition and water. The probiotic composition comprises at least one viable probiotic microorganism. The probiotic composition may comprise one or more colony-forming probiotic bacterial strains, which may be spore-based probiotic bacterial strains. In some embodiments, the probiotic composition comprises a species of Bacillus subtilis. In further embodiments, the probiotic composition comprises Bacillus subtilis HU58(trademark) (Bacillus subtilis having accession number EF101709). Bacillus species may exist in the form of spores (also called endospores) or in a vegetative state.
[0025] Acidic Probiotic Beverages: In relation to the present invention, “acidic probiotic beverages” comprise at least a probiotic composition and water, and have a low pH level, typically less than pH 4.6. Examples of acidic probiotic beverages include fruit juices, fruit drinks, flavored waters, sodas, sports drinks, yogurt-based beverages (which may be dairy-based or dairy substitute-based), kefir-based beverages, kombucha-based beverages, tea-based beverages, or coffee-based beverages. Fruit juices may be fermented fruit juices. Acidic probiotic beverages can be obtained by a fermentation process that increases acidity to create an environment that contributes to the growth and activity of probiotics. In addition, certain dairy-based and plant-based fermented beverages, such as certain yogurt drinks and fermented buttermilk, also fall into this category. In a preferred embodiment, the acidic probiotic beverage according to the present invention has a pH less than 4.0. In another preferred embodiment, the acidic probiotic beverage according to the present invention has a pH of 2.0 to 4.0, for example, pH 2.0 to 3.7, for example, pH 2.0 to 3.5, for example, pH 2.0 to 3.0.
[0026] Prebiotics and Postbiotics: In connection with the present invention, the terms “prebiotics” and “postbiotics” have their usual meanings as are well known and understood by those skilled in the art. “Prebiotics” as used herein refers to any compound, nutrient or additional microorganism used to support or enhance the health benefits of a desired probiotic, or to support the growth and / or activity of a probiotic microorganism. “Postbiotics” refers to the cells of a probiotic that are killed by heat or other means and delivered to the consumer as dead cells.
[0027] Spores: The terms “spores” and “endospores” are used interchangeably and have their usual meanings as are well known and understood by those skilled in the art. As used herein, the term spore refers to a dormant, protected microorganism.
[0028] Spore-forming microorganisms: The term "spore-forming microorganisms" refers to microorganisms capable of forming spores. In the method of the present invention, viable Bacillus subtilis spores are derived from spore-forming microbial cells, which may be wild-type cells or their variants. In one embodiment, spore-forming microbial cells are obtained from an environmental niche or a microbiome niche.
[0029] Stable: The term “stable” is a term known in the art, and in a preferred embodiment, stable means the ability of a microorganism to remain in a spore form until administered to a subject, in particular a human subject, to improve the subject’s health.
[0030] Suspensions: The term "suspension" refers to materials suspended in a liquid.
[0031] Viable: As used herein in reference to Bacillus subtilis spores, the terms “viable” or “viability” mean that the cells or spores can grow on or in a suitable growth medium or substrate if conditions such as temperature, humidity, nutrient availability, and pH are favorable for germination and / or microbial growth within a given time.
[0032] This disclosure provides a heat-treated acidic beverage containing a probiotic composition and a method for producing such a heat-treated acidic probiotic beverage.
[0033] It is well known in the art that lowering pH reduces the heat resistance and viability of bacterial strains, including the spore viability of spores of spore-forming probiotic bacteria, such as Bacillus species. Surprisingly, this specification shows that the Bacillus subtilis strain has better viability than other spore-forming probiotic bacteria, including other Bacillus species, such as Bacillus coagulans. The ability to survive in low pH and high temperature environments indicates that the Bacillus subtilis strain may survive pasteurization and / or other heat treatments used to sterilize beverages. Therefore, the Bacillus subtilis strain may be more suitable for certain probiotic applications, such as acidic probiotic beverages that can be stored at room temperature and require sterilization or pasteurization steps.
[0034] In a first aspect, the present invention relates to a method for producing a heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, comprising the following steps: (a) A step of preparing an acidic beverage containing viable Bacillus subtilis spores, wherein the pH of the beverage is 2.0 to 4.6, and (b) The step of heat-treating the beverage and The present invention relates to a method that includes a method in which at least 70% of the initial Bacillus subtilis spores remain viable after heat treatment.
[0035] Acidic probiotic beverages include any acidic beverage to which probiotics may be added. In some embodiments, the pH of acidic probiotic beverages is 2.0 to 4.6. In further embodiments, the pH of acidic probiotic beverages is 3.7 to 4.3. Acidic beverages typically have a pH of 4.6 or less. Juices and sodas often have a pH of less than 4.0. Acids and acidulants provide a sour and pungent taste that balances the sweetness of sugars present in the beverage and are a major factor in the taste of the beverage. Acids can also act as preservatives, reducing the growth of bacteria and fungi in the beverage, thereby improving shelf life, also known as shelf life. Weak acids and / or acids naturally present in fruits can be used to produce acidic beverages. Citric acid, naturally present in citrus fruits, and malic acid, naturally present in apples, pears, and cherries, are added to many beverages, including fruit drinks, sports drinks, and tea-based beverages. Phosphoric acid is added to cola drinks. Acetic acid, adipic acid, ascorbic acid, fumaric acid, butyric acid, gluconic acid, lactic acid, tartaric acid, and sorbic acid can also be used to produce acidic beverages.
[0036] In some embodiments, the acidic probiotic beverage may be a fruit juice, fruit drink, flavored water, soda, sports drink, yogurt-based beverage, kefir-based beverage, kombucha-based beverage, tea-based beverage, or coffee-based beverage.
[0037] In some embodiments, the acidic probiotic beverage may be a fruit juice, fruit drink, flavored water, soda, sports drink, yogurt-based beverage, kombucha-based beverage, tea-based beverage, or coffee-based beverage.
[0038] In some embodiments, the acidic probiotic beverage is selected from fruit juice, fruit drink, flavored water, soda, sports drink, yogurt-based beverage, kefir-based beverage, and kombucha-based beverage.
[0039] In some embodiments, the acidic probiotic beverage is a beverage flavored with fruit juice, fruit juice cocktail, lemonade, cider, or fruit juice. The fruit components may be orange, grapefruit, lemon, lime, apple, pear, peach, apricot, prune, plum, strawberry, raspberry, cranberry, blueberry, pineapple, banana, mango, grape, tomato, pomegranate, papaya, coconut, kiwi, lychee, yuzu, or any combination thereof.
[0040] In some embodiments, the acidic probiotic beverage is soda. Soda is typically a carbonated beverage containing carbonated water, sweeteners, and natural and / or artificial flavorings. Soda may be seltzer. Soda may be sugar-free and therefore may contain no sweeteners or only artificial sweeteners. Soda may be "sugar-free" and in that case may be carbohydrate-free. Soda may also contain caffeine, colorants, preservatives, and optionally additional ingredients. Soda may also be called a soft drink, seltzer, "pop," or "soda pop."
[0041] In some embodiments, the acidic probiotic beverage is flavored water. The flavored water may be carbonated water, such as sparkling water.
[0042] In some embodiments, an acidic probiotic beverage is a sports drink. Sports drinks contain electrolytes such as sodium, potassium, and chloride, and also carbohydrates, typically and often in the form of sugars such as glucose and sucrose, or high-fructose corn syrup. Sports drinks may be sugar-free, and therefore may contain no sweeteners, or only artificial sweeteners. Sports drinks may be "sugar-free," in which case they may contain no carbohydrates. Sports drinks may contain caffeine, vitamins, minerals, proteins, amino acids, natural or artificial flavorings, and additional ingredients of their choice. Sports drinks may also be called vitamin water, fitness water, fortified water, energy drink, or hydration drink.
[0043] In some embodiments, the acidic probiotic beverage is tea or a tea-based beverage. The tea may be green tea, black tea, oolong tea, yellow tea, white tea, decaffeinated tea, herbal tea, or any combination thereof. The herbal tea may be rosehip tea, chamomile tea, gynostemma tea, peppermint tea, rooibos tea, ginger tea, ginseng tea, lemongrass tea, or any combination thereof. In some embodiments, the tea-based beverage is fermented tea. In some embodiments, the acidic probiotic beverage is tea or a tea-based beverage having a pH of less than 4.0.
[0044] In further embodiments, the fermented tea is kombucha or a kombucha-based beverage. Kombucha is produced by symbiotic fermentation of tea with added sugar, using a symbiotic culture of bacteria and yeast. Kombucha or a kombucha-based beverage may further contain fruit juice and / or spices. In some embodiments, kombucha or a kombucha-based beverage may contain ethanol or be alcoholic. In other embodiments, kombucha or a kombucha-based beverage is non-alcoholic.
[0045] In some embodiments, the acidic probiotic beverage is milk-based. The milk-based beverage may be derived from fermented dairy products such as kefir, ayran, and yogurt.
[0046] In some embodiments, the acidic probiotic beverage is yogurt-based. The yogurt-based beverage may be based on dairy products and / or dairy substitutes. Examples of dairy substitute yogurt-based beverages include grain-based yogurt-based beverages, such as oat-based or corn-based yogurt-based beverages; nut-based yogurt-based beverages, such as peanut-based, almond-based, coconut-based, cashew-based, hazelnut-based, or macadamia-nut-based yogurt-based beverages; or legume-based yogurt-based beverages, such as chickpea-based, broad bean-based, lentil-based, pea-based, or soybean-based yogurt-based beverages.
[0047] In some embodiments, the acidic probiotic beverage is coffee or a coffee-based beverage. The coffee may be roasted coffee, unroasted green coffee, decaffeinated coffee, or any combination thereof. The coffee or coffee-based beverage may further contain dairy ingredients, such as milk or cream and / or plant-based substitutes, such as oat milk, almond milk, soy milk, rice milk or cashew milk, or any other non-dairy substitute known in the art. The coffee or coffee-based beverage may further contain flavoring ingredients, such as cocoa, chocolate, artificial cocoa composition, vanilla, artificial vanilla composition, or any combination thereof.
[0048] Acidic probiotic beverages may further contain one or more additional ingredients to improve or alter the taste of the beverage. These additional ingredients may include acidulants, thickeners, buffers or pH adjusters, chelating agents, colorants, emulsifiers, excipients, flavoring agents, osmotic agents, acceptable carriers, preservatives, stabilizers, sugars, sweeteners, texture enhancers, minerals, and / or vitamins. Additional ingredients may be added in any appropriate amount.
[0049] It is further recognized by those skilled in the art that acidic probiotic beverages, in addition to probiotics, contain food components and / or components for nutritional benefits. Additional components include vitamins, minerals, amino acids, proteins, fiber, prebiotics (such as fructooligosaccharides, galactooligosaccharides, inulin, and polydextrose), and postbiotics.
[0050] The heat-treated acidic probiotic beverage of the present invention can be ingested by human or animal subjects, preferably human subjects. In some embodiments, the heat-treated acidic probiotic beverage, upon consumption, provides beneficial effects to the subject, such as beneficial effects on the subject's intestinal health.
[0051] In humans, the gut is the primary site of the human microbiome and is considered essential for human health throughout life. The gut microbiome facilitates the digestion of food, the regulation of the immune system, protection from other disease-causing bacteria, and the production of vitamins (including B vitamins B12, thiamine, and riboflavin, as well as vitamin K, which is necessary for blood clotting).
[0052] The gut microbiome is a vast population of bacteria, viruses, fungi, and protists that colonize the digestive tract, numbering ten times more than human cells. Exposure to these microbiomes in early childhood through birthing methods (maternal microorganisms), infant food (selective substrates), antibiotics (selective killing), probiotics (selective enrichment), and the physical environment (environmental microorganisms) leads to the colonization of the gut microbiota, which contributes to the development of the immune system, gut homeostasis, and host metabolism.
[0053] Disruption of the gut microbiota is associated with a growing number of diseases. See, for example, MBAzad, et al., Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months, 185 CAN.MED.ASS'N J.385 (2013), which is incorporated herein by reference in its entirety. Recent advances in metagenomics have deepened our understanding of the gut microbiome and suggest that it may provide important immune and metabolic benefits to humans.
[0054] The heat-treated acidic probiotic beverages disclosed herein contain probiotics in the form of Bacillus subtilis spores. Preferably, for Bacillus subtilis spores to induce a probiotic effect on a subject after ingestion of the heat-treated acidic probiotic beverage, the probiotics should remain substantially viable at the intestinal level. There is some evidence in human studies supporting the importance of viability, with viable bacteria having a greater immunological effect than inviolable bacteria. See, for example, M. Kaila, et al., Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhea, 72 ARCHIVES OF DISEASE IN CHILDHOOD 51 (1995), and PvKirjavainen, et al., Probiotic bacteria in the management of atopic disease: underscoring the importance of viability, 36 J. PEDIATRIC GASTROENTEROLOGY & NUTRITION 223 (2003). Each of these is incorporated herein by reference in whole.
[0055] In a preferred embodiment, the probiotics are resistant to gastric acid digestion and bile salts in order to reach the intestines undamaged, and are non-pathogenic to those who consume the instant probiotic food.
[0056] Many commercially available probiotics are spore-forming Gram-positive bacteria, and are supplied in spore form, also known as endospores. As spores, bacteria can survive harsh environments, allowing for processing in a dry form; for this reason, bacteria can be supplied, for example, in capsules and powders. When capsules or powders are ingested, the probiotics are then introduced into the intestines. However, ingesting probiotics in capsule or powder form may reduce their effectiveness. Liquid media allow for better absorption of probiotics and better distribution throughout the digestive tract.
[0057] The appropriate liquid medium for delivering probiotics to the intestines must be a beverage that consumers wish to drink. Acidic beverages include most juices, tea-based drinks, coffee-based drinks, sodas, and sports drinks, and are enjoyed by many consumers worldwide. To be considered safe and shelf-stable, acidic beverages must be sterilized or pasteurized, which are typically provided as heat-treated products. However, even though spore-forming probiotics can survive under harsher conditions, most spore-forming bacteria cannot survive under all harsh conditions, especially when there are multiple environmental stressors. Most probiotic strains, even those that can be supplied as spores, have poor survival rates in the low-pH, high-temperature environments required to sterilize acidic beverages. One solution is to combine the acidic beverage and the spore-forming probiotics by sterilizing them separately and then packaging them together under sterile conditions (see, for example, International Publication No. 2019 / 231910, which is incorporated herein by reference in its entirety). However, such manufacturing methods are cumbersome, require multiple additional processing steps, and increase manufacturing costs.
[0058] The present invention includes a method for producing a heat-treated acidic probiotic beverage in which probiotics containing viable Bacillus subtilis spores are added to an acidic beverage, and the beverage is then heat-treated so that an effective amount of Bacillus subtilis spores survive the heat treatment. Since the probiotics are not sterilized separately from the beverage and then combined with the beverage under sterile conditions, the number of steps required for processing the beverage is reduced, resulting in high cost-effectiveness and resource efficiency. The present invention also includes a heat-treated acidic probiotic beverage produced by the method of the present invention. Preferably, the heat treatment is pasteurization or retort sterilization.
[0059] Probiotics are measured in colony-forming units ("CFU") and may be measured as CFU / g or CFU / volume. Alternatively, a given dose of probiotics may be delivered in units of CFU as a whole. The effective dose, also called the effective amount, is typically several hundred million CFU per gram or milliliter, and may be higher. In some embodiments, probiotics are taken with meals. In other embodiments, probiotics are taken between meals. Probiotics may have better survival when taken with a liquid that can dilute stomach acid and allow them to move more quickly into the digestive tract. Probiotics may be taken for short or long periods.
[0060] This invention is based on the surprising discovery that several strains of Bacillus subtilis are highly resistant to sterilization heat treatment under liquid acidic conditions.
[0061] In some embodiments, the acidic probiotic beverage of the present invention contains spores of Bacillus subtilis HU58® (also known as Bacillus subtilis HU58), which is deposited with the National Center for Biotechnology Research under accession number EF101709. The number assigned to Bacillus HU58 by the Bacillus Genetic Stock Center ("BGSC") is 3A34, and the strain number assigned by NCIMB Ltd. is 30283. HU58® is commercially available as a dried spore composition and is manufactured and sold, for example, by Microbiome Labs UK Ltd. The commercially available Bacillus subtilis HU58® spore composition is also sold by Novonesis (formerly Novozymes A / S, Bagsvaerd, Denmark) under the trademark name ProSilience® HU58®.
[0062] In some embodiments, the acidic probiotic beverage of the present invention contains spores of Bacillus subtilis DE111 (registered trademark) (also known as Bacillus subtilis DE111 or Bacillus subtilis inaquosorum), which is deposited with the Agricultural Research Service Culture Collection (NRRL) under accession number NRRL B-67989.
[0063] In some embodiments, the acidic probiotic beverage of the present invention contains two or more strains of Bacillus subtilis. In other embodiments, the beverage of the present invention contains only one strain of Bacillus subtilis.
[0064] In some embodiments, heat-treated acidic probiotic beverages may contain additional probiotics in addition to Bacillus subtilis spores. These additional probiotics may be probiotic microorganisms in spore form or vegetative form. These additional probiotics will also be resistant to the low pH and high-temperature heat treatment required for sterilization of the beverage. Examples of additional probiotic microorganisms include, but are not limited to, strains of the genera Lactobacillus, Bacillus, Bifidobacterium, Lactococcus, Propionibacterium, Enterococcus, Escherichia, Streptococcus, Pediococcus, and Saccharomyces. For example, further probiotic microorganisms include Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus gasseri, Lactobacillus helveticus, Lactobacillus johnsonii, Lactobacillus lactis, Lactobacillus plantarum, and Lactobacillus reuteri. Lactobacillus reuteri, Lactobacillus salivarius, Lactobacillus paracaseiBifidobacterium species (paracasei), Bifidobacterium longum, Bifidobacterium infantis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium adelocentis, Bifidobacterium lactis, Bacillus coagulans, Bacillus licheniformis, Enterococcus faecalis, Enterococcus faecium The following may be selected from the list: *Lactococcus faecium*, *Lactococcus lactis*, *Streptococcus salivarius*, *Saccharomyces cerevisiae*, *Saccharomyces boulardii*, and combinations thereof.
[0065] In the method of the present invention, an acidic probiotic beverage containing viable Bacillus subtilis spores is heat-treated. After heat treatment, the number of viable Bacillus subtilis spores is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before heat treatment.
[0066] In some embodiments, the acidic probiotic beverage comprises a sufficient amount of spores such that an effective amount of the spores remains viable after heat treatment. In some embodiments, the effective amount of B. subtilis spores is at least 1×10 4 CFU / ml. In some embodiments, the concentration of the B. subtilis strain in the acidic probiotic beverage before heat treatment is at least 1×10 4 colony forming units (CFU) / ml, at least 3×10 4 CFU / ml, at least 5×10 4 CFU / ml, at least 7×10 4 CFU / ml, at least 9×10 4 CFU / ml, at least 1×10 5 colony forming units (CFU) / ml, at least 5×10 5 CFU / ml, at least 7×10 5 CFU / ml, at least 9×10 5 CFU / ml, at least 1×10 6 CFU / ml, at least 2×10 6 CFU / ml, at least 3×10 6 CFU / ml, at least 4×10 6 CFU / ml, at least 5×10 6 CFU / ml, at least 6×10 6 CFU / ml, at least 7×10 6 CFU / ml, at least 8×10 6 CFU / ml, at least 9×10 6 CFU / ml, at least 1×10 7 CFU / ml, at least 2×10 7 CFU / ml, at least 3×10 7 CFU / ml, at least 4×10 7 CFU / ml, at least 5×10 7 CFU / ml, at least 6×10 7 CFU / ml, at least 7×10 7 CFU / ml, at least 8×10 7 CFU / ml, at least 9×10 7 CFU / ml, at least 1×10 8CFU / ml, at least 2 × 10⁻⁶ 8 CFU / ml, at least 3 × 10⁶ 8 CFU / ml, at least 4 × 10 8 CFU / ml, at least 5 × 10 8 CFU / ml, at least 6 × 10⁶ 8 CFU / ml, at least 7 × 10⁶ 8 CFU / ml, at least 8 × 10 8 CFU / ml, at least 9 × 10 8 CFU / ml, at least 1 × 10⁶ 9 CFU / ml, 5 x 10 9 CFU / ml, at least 1 × 10⁶ 10 CFU / ml, at least 5 × 10 10 CFU / ml, at least 1 × 10⁶ 11 CFU / ml, at least 5 × 10 11 CFU / ml or at least 1 × 10⁶ 12 It could be CFU / ml.
[0067] After heat treatment, the probiotic beverage of the present invention contains an effective amount of Bacillus subtilis spores. In some embodiments, the effective amount of Bacillus subtilis spores is at least 1 × 10⁻⁶. 4 The concentration is CFU / ml. In some embodiments, the probiotic beverage after heat treatment contains at least 1 × 10⁻¹⁶ CFU / ml. 4 CFU / ml, at least 2 × 10⁻⁶ 4 CFU / ml, at least 3 × 10⁶ 4 CFU / ml, at least 4 × 10 4 CFU / ml, at least 5 × 10 4 CFU / ml, at least 6 × 10⁶ 4 CFU / ml, at least 7 × 10⁶ 4 CFU / ml, at least 8 × 10 4 CFU / ml, at least 9 × 10 4 CFU / ml, at least 1 × 10⁶ 5 CFU / ml, at least 2 × 10⁻⁶ 5 CFU / ml, at least 3 × 10⁶ 5 CFU / ml, at least 4 × 10 5CFU / ml, at least 5×10 5 CFU / ml, at least 6×10 5 CFU / ml, at least 7×10 5 CFU / ml, at least 8×10 5 CFU / ml, at least 9×10 5 CFU / ml, at least 1×10 6 CFU / ml, at least 2×10 6 CFU / ml, at least 3×10 6 CFU / ml, at least 4×10 6 CFU / ml, at least 5×10 6 CFU / ml, at least 6×10 6 CFU / ml, at least 7×10 6 CFU / ml, at least 8×10 6 CFU / ml, at least 9×10 6 CFU / ml, at least 1×10 7 CFU / ml, at least 2×10 7 CFU / ml, at least 3×10 7 CFU / ml, at least 4×10 7 CFU / ml, at least 5×10 7 CFU / ml, at least 6×10 7 CFU / ml, at least 7×10 7 CFU / ml, at least 8×10 7 CFU / ml, at least 9×10 7 CFU / ml, at least 1×10 8 CFU / ml, at least 2×10 8 CFU / ml, at least 3×10 8 CFU / ml, at least 4×10 8 CFU / ml, at least 5×10 8 CFU / ml, at least 6×10 8 CFU / ml, at least 7×10 8 CFU / ml, at least 8×10 8 CFU / ml, at least 9×10 8 CFU / ml, at least 1×10 9 CFU / ml, 5×10 9 CFU / ml, at least 1×1010 CFU / ml, at least 5×10 10 CFU / ml, at least 1×10 11 CFU / ml, at least 5×10 11 CFU / ml or at least 1×10 12 CFU / ml.
[0068] In some embodiments, the probiotic acidic beverage is canned or packaged into a container prior to heat treatment such that in-container pasteurization is performed. In other embodiments, the beverage is heat treated and then canned or packaged into a container by aseptic filling or hot filling using methods known in the art.
[0069] In the method of the present invention, the acidic probiotic beverage is heat treated to be sterilized. The heat treatment may also be referred to as pasteurization. The heat treatment is intended to make the beverage safe for consumption by killing harmful microorganisms, thereby reducing the risk of food poisoning. The heat treatment also extends the shelf life of the beverage or enhances its room temperature storage stability, because the heat treatment removes microorganisms in the beverage that may degrade the beverage by spoiling the beverage or reducing the quality of the beverage. In some embodiments, the heat treatment is performed at 85 to 95°C for 5 to 30 minutes. In a further embodiment, the heat treatment is performed at 85 to 95°C for 10 to 15 minutes. In some embodiments, the heat treatment is performed at 95°C for 5, 10, 15, 20, 25 or 30 minutes. In some embodiments, the heat treatment is performed at 85 to 95°C for 1 minute or less. In some embodiments, the heat treatment is performed at 85 to 95°C for 10, 15, 20, 25, 30, 35, 40, 45, 50, 55 or 60 seconds.
[0070] In some embodiments, the acidic probiotic beverage is heat treated by high-temperature short-time (HTST) sterilization. In this regard, the beverage is heated to a temperature of 71.5 to 74°C for 15 to 30 seconds, or heated to a temperature of 74 to 76°C for 15 to 20 seconds. After the heat treatment, the beverage may then be quenched to 4 to 5.5°C.
[0071] In some embodiments, the acidic probiotic beverage is heat-treated by high-temperature sterilization. In this case, the beverage is heated to a temperature of 70-75°C for 20-30 minutes. In some embodiments, the beverage is heated to a temperature of 80-85°C for 20-30 seconds.
[0072] In some embodiments, the acidic probiotic beverage is heat-treated by ultra-high temperature (UHT) treatment. The UHT treatment may be direct or indirect. In some embodiments, the UHT treatment is 1 to 10 seconds at 135 to 154°C. In further embodiments, the UHT treatment is 3, 4, 5, 6, 7, 8, 9, or 10 seconds at 140 to 150°C. In further embodiments, the UHT treatment is 3, 4, 5, 6, 7, 8, 9, or 10 seconds at 140 to 145°C. In some embodiments, the UHT treatment is 4, 5, 6, 7, or 8 seconds at 143°C.
[0073] In some embodiments, the probiotics in a heat-treated acidic probiotic beverage are determined to have a good viability several days after heat treatment. In the methods and compositions of the present invention, the number of viable Bacillus subtilis spores after 7 days of storage is at least 60%, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before heat treatment.
[0074] Preferred Embodiment 1. A method for producing a heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, comprising the following steps: (a) A step of preparing an acidic beverage containing viable Bacillus subtilis spores, wherein the pH of the beverage is 2.0 to 4.6, and (b) The step of heat-treating the beverage and A method that includes a method in which at least 70% of the initial Bacillus subtilis spores remain viable after heat treatment.
[0075] 2. At least 1 × 10 4 , 5×10 4 , 1 x 10 5 , 2×10 5 , 3 x 10 5 , 4×10 5 , 5×10 5 , 6×10 5 , 7×10 5 , 8×10 5 , 9×10 5 , 1 x 10 6 , 2×10 6 , 3 x 10 6 , 4×10 6 , 5×10 6 , 6×10 6 , 7×10 6 , 8×10 6 , 9×10 6 or at least 1 × 10 7 The method according to Embodiment 1, wherein Bacillus subtilis spores at a CFU / ml concentration are viable after heat treatment.
[0076] 3. The method according to Embodiment 1 or 2, wherein the number of viable Bacillus subtilis spores is at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before heat treatment.
[0077] 4. The method according to any one of Embodiments 1 to 3, wherein at least 70% of the spores present before heat treatment are viable 7 days after heat treatment.
[0078] 5. At least 1 × 10 4 , 5×10 4 , 1 x 10 5 , 2×10 5 , 3 x 10 5 , 4×105 , 5×10 5 , 6×10 5 , 7×10 5 , 8×10 5 , 9×10 5 , 1 x 10 6 , 2×10 6 , 3 x 10 6 , 4×10 6 , 5×10 6 , 6×10 6 , 7×10 6 , 8×10 6 , 9×10 6 or at least 1 × 10 7 The method according to any one of Embodiments 1 to 4, wherein Bacillus subtilis spores at a CFU / ml level are viable 7 days after heat treatment.
[0079] 6. The method according to any one of Embodiments 1 to 5, wherein at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before heat treatment are viable 7 days after heat treatment.
[0080] 7. The method according to any one of Embodiments 1 to 6, wherein the heat treatment is an ultra-high temperature (UHT) treatment, a high temperature short time (HTST) treatment, or a low temperature long time (LTLT) treatment.
[0081] 8. The method according to Embodiment 7, wherein the UHT treatment is performed at 135-154°C for 1-10 seconds.
[0082] 9. The method according to Embodiment 7, wherein the HTST treatment is performed at 70-85°C for 10-30 seconds.
[0083] 10. The method according to Embodiment 7, wherein the LTLT treatment is performed at 55-70°C for 15-30 minutes.
[0084] 11. The beverage having a pH of less than 4.0, according to any one of Embodiments 1 to 10.
[0085] 12. The method according to any one of Embodiments 1 to 11, wherein the beverage has a pH of 2.0-4.0, 2.0-3.7, 2.0-3.5, 2.0-3.0, 2.5-4.5, or 2.5-3.5.
[0086] 13. The method according to any one of Embodiments 1 to 12, wherein the beverage has a pH of 2.0 to 4.0, 2.5 to 4.5, or 2.5 to 3.5.
[0087] 14. The method according to any one of Embodiments 1 to 13, wherein the beverage is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, yogurt-based beverage, tea-based beverage, or coffee-based beverage.
[0088] 15. The method according to any one of Embodiments 1 to 14, wherein the beverage is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, or yogurt-based beverage.
[0089] 16. The method according to any one of Embodiments 1 to 15, wherein the beverage is a fruit juice, fruit drink, flavored water, soda, or sports drink.
[0090] 17. The method according to any one of Embodiments 1 to 15, wherein the beverage is a kombucha-based beverage.
[0091] 18. The method according to any one of Embodiments 1 to 15 or 17, wherein the beverage is a non-alcoholic kombucha-based beverage.
[0092] 19. The method according to any one of Embodiments 1 to 18, wherein the beverage is a carbonated beverage.
[0093] 20. The method according to any one of Embodiments 1 to 19, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709) and / or Bacillus subtilis DE111 (registered trademark) (Bacillus subtilis having accession number NRRL B-67989).
[0094] 21. The method according to any one of Embodiments 1 to 20, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709).
[0095] 22. The method according to any one of Embodiments 1 to 21, wherein the beverage contains viable Bacillus subtilis spores derived from two or more strains.
[0096] 23. The method according to any one of Embodiments 1 to 22, wherein the beverage further comprises viable spores derived from at least one probiotic species other than Bacillus subtilis.
[0097] 24. The method according to any one of Embodiments 1 to 23, wherein the beverage further comprises viable spores derived from at least one probiotic species of the genera Lactobacillus, Bacillus, Bifidobacterium, Lactococcus, Propionibacterium, Enterococcus, Escherichia, Streptococcus, Pediococcus and / or Saccharomyces.
[0098] 25. A method for producing a heat-treated acidic probiotic beverage containing viable spores of Bacillus subtilis HU58 (trademark) (accession number EF101709), comprising the following steps: (a) A step of preparing an acidic beverage containing viable Bacillus subtilis HU58™ spores, wherein the pH of the beverage is 2.0 to 4.6, and (b) The step of heat-treating the beverage and A method that includes a first Bacillus subtilis (B. subtilis) HU58™ spore, in which at least 70% of the spores remain viable after heat treatment.
[0099] 26. A heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, with at least 1 × 10⁻⁶ 4 CFU / ml of Bacillus subtilis spores are viable in this acidic probiotic beverage.
[0100] 27. The heat-treated acidic probiotic beverage according to Embodiment 26, wherein the pH of the beverage is pH 2.0 to 4.6.
[0101] 28. A heat-treated acidic probiotic beverage according to Embodiment 26 or 27, wherein the pH of the beverage is less than pH 4.0.
[0102] 29. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 28, wherein the beverage has a pH of 2.0 to 4.0, 2.0 to 3.7, 2.0 to 3.5, 2.0 to 3.0, 2.5 to 4.5, or 2.5 to 3.5.
[0103] 30. The method according to any one of embodiments 26 to 29, wherein the beverage has a pH of 2.0 to 4.0, 2.5 to 4.5, or 2.5 to 3.5.
[0104] 31. At least 1 × 10 4 , 2×10 4 , 3 x 10 4 , 4×104 , 5×10 4 , 6×10 4 , 7×10 4 , 8×10 4 , 9×10 4 , 1 x 10 5 , 2×10 5 , 3 x 10 5 , 4×10 5 , 5×10 5 , 6×10 5 , 7×10 5 , 8×10 5 , 9×10 5 , 1 x 10 6 , 2×10 6 , 3 x 10 6 , 4×10 6 , 5×10 6 , 6×10 6 , 7×10 6 , 8×10 6 , 9×10 6 , 1 x 10 7 , 2×10 7 , 3 x 10 7 , 4×10 7 , 5×10 7 , 6×10 7 , 7×10 7 , 8×10 7 , 9×10 7 or at least 1 × 10 8 A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 30, in which CFU / ml of Bacillus subtilis spores are viable.
[0105] 32. At least 1 × 10 5 , 2×10 5 , 3 x 10 5 , 4×10 5 , 5×10 5 , 6×10 5 , 7×10 5 , 8×10 5 , 9×10 5 , 1 x 10 6 , 2×10 6 , 3 x 10 6 , 4×10 6 , 5×10 6 , 6×10 6, 7×10 6 , 8×10 6 , 9×10 6 or at least 1 × 10 7 A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 31, wherein Bacillus subtilis spores at a concentration of CFU / ml are viable after storage for 7 days.
[0106] 33. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 32, which is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, yogurt-based beverage, tea-based beverage, or coffee-based beverage.
[0107] 34. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 33, which is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, or yogurt-based beverage.
[0108] 35. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 34, which is a fruit juice, fruit drink, flavored water, soda, or sports drink.
[0109] 36. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 35, which is a kombucha-based beverage.
[0110] 37. A heat-treated acidic probiotic beverage according to any one of embodiments 26-34 or 36, which is a non-alcoholic kombucha-based beverage.
[0111] 38. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 37, which is a carbonated beverage.
[0112] 39. A heat-treated acidic probiotic beverage according to any one of Embodiments 26 to 38, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709) and / or Bacillus subtilis DE111 (registered trademark) (Bacillus subtilis having accession number NRRL B-67989).
[0113] 40. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 39, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709).
[0114] 41. A heat-treated acidic probiotic beverage according to any one of Embodiments 26 to 40, comprising viable Bacillus subtilis spores derived from 41.2 or more strains.
[0115] 42. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 41, comprising viable spores derived from at least one probiotic species other than Bacillus subtilis.
[0116] 43. A heat-treated acidic probiotic beverage according to any one of embodiments 26 to 42, comprising viable spores derived from at least one probiotic species of the genera Lactobacillus, Bacillus, Bifidobacterium, Lactococcus, Propionibacterium, Enterococcus, Escherichia, Streptococcus, Pediococcus and / or Saccharomyces.
[0117] 44. A heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, manufactured by the method described in any one of Embodiments 1 to 25. [Examples]
[0118] Example 1: Spore survival during pasteurization of acidic beverages In this example, the survival of endospores of Bacillus probiotic strains was evaluated to test the performance of probiotics in pasteurized acidic beverages. Endospores of three commercially available Bacillus strains, namely Bacillus subtilis HU58® (Novozymes A / S, Bagsvaerd, Denmark), Bacillus subtilis DE111® (Deerland Probiotics and Enzymes, Kennesaw, Georgia, USA), and B. coagulans BC30® (Kerry Group, Tralee, Ireland), were included in the test.
[0119] To prepare the spore suspension, the endospores of each strain were diluted in three different acidic solutions at pH 2.5, pH 3.5, and pH 4.5. The amount of spores added was 1 × 10⁻⁶ to mimic the standard amount added in beverages. 6 Different pH solutions based on citrate and disodium hydrogen phosphate were prepared at a target buffer strength of 20 mM, with a concentration of CFU / mL. The samples were then subjected to a heat shock at 72°C for 30 seconds, followed by incubation at room temperature for 7 days. After 7 days, the samples were serially diluted and then spread onto can templates suitable for the growth of Bacillus strains. The dilutions and can templates used were the same for all three test strains. The resulting colony-forming units per milliliter (CFU / mL) were recorded by counting the number of colonies formed on the can templates after incubation at 37°C.
[0120] To evaluate the immediate effects of heat treatment at low pH, serial dilutions based on samples taken on day 0 (i.e., immediately after the heat shock) were also included in the test. Finally, control samples that were not subjected to heat shock were included to determine the effect of heat treatment on endospore activation.
[0121] The test results are shown in the graph in Figure 1. From Figure 1, it is clear that two commercially available Bacillus subtilis strains (HU58® and DE111®) perform better than the commercially available B. coagulans strain (BC30®). This is evident from the higher CFU / mL observed in both HU58 and DE111 immediately after pasteurization ("Day 0") and after incubation ("Day 7"). The difference in stability is particularly pronounced at lower pH levels (pH 2.5 and pH 3.5). Acidic beverages in the pH range of 2.5 to 3.5 include fruit juices, fruit drinks (including lemonade and cider), soda, sports drinks, and tea-based beverages (including kombucha-based beverages).
[0122] Therefore, as illustrated herein by two commercially available strains, the stability observed in the endospores of Bacillus subtilis (B. subtilis) makes it possible to produce heat-treated acidic probiotic beverages in which the probiotic Bacillus subtilis spores are added to the beverage before pasteurization or sterilization by heat treatment. Thus, using the method of the present invention, a more stable probiotic-based acidic beverage can be obtained with improved storage stability and a reduced risk of contamination.
Claims
1. A method for producing a heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, comprising the following steps: (a) A step of preparing an acidic beverage containing viable Bacillus subtilis spores, wherein the pH of the beverage is 2.0 to 4.6, (b) The step of heat-treating the beverage and A method comprising a method wherein at least 70% of the initial Bacillus subtilis spores are viable after the heat treatment.
2. The method according to claim 1, wherein the number of viable Bacillus subtilis spores is at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before the heat treatment.
3. The method according to claim 1 or 2, wherein at least 70% of the spores present before the heat treatment are viable 7 days after the heat treatment.
4. The method according to any one of claims 1 to 3, wherein at least 75%, at least 80%, at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% of the spores present before the heat treatment are viable 7 days after the heat treatment.
5. The method according to any one of claims 1 to 4, wherein the heat treatment is an ultra-high temperature (UHT) treatment, a high temperature short time (HTST) treatment, or a low temperature long time (LTLT) treatment.
6. The method according to any one of claims 1 to 5, wherein the beverage is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, yogurt-based beverage, tea-based beverage, or coffee-based beverage.
7. The method according to any one of claims 1 to 6, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709) and / or Bacillus subtilis DE111 (registered trademark) (Bacillus subtilis having accession number NRRL B-67989).
8. The method according to any one of claims 1 to 7, wherein the beverage further comprises viable spores derived from at least one probiotic species other than Bacillus subtilis.
9. The method according to any one of claims 1 to 8, wherein the beverage has a pH of less than 4.0, for example, a pH of 2.0 to 4.0, 2.0 to 3.7, 2.0 to 3.5, 2.0 to 3.0, or 2.5 to 3.
5.
10. A heat-treated acidic probiotic beverage containing viable Bacillus subtilis spores, with at least 1 × 10 4 A heat-treated acidic probiotic beverage in which Bacillus subtilis spores at a CFU / ml concentration are viable, and the pH of the beverage is between pH 2.0 and 4.
6.
11. The heat-treated acidic probiotic beverage according to claim 10, having a pH of less than 4.0, for example, a pH of 2.0 to 4.0, 2.0 to 3.7, 2.0 to 3.5, 2.0 to 3.0, or 2.5 to 3.
5.
12. at least 1×10 5 , 2×10 5 , 3×10 5 , 4×10 5 , 5×10 5 , 6×10 5 , 7×10 5 , 8×10 5 , 9×10 5 , 1×10 6 , 2×10 6 , 3×10 6 , 4×10 6 , 5×10 6 , 6×10 6 , 7×10 6 , 8×10 6 , 9×10 6 or at least 1×10 7 CFU / ml of the said B. subtilis spores are viable after 7 days of storage, the heat-treated acidic probiotic beverage according to claim 10 or 11.
13. A heat-treated acidic probiotic beverage according to any one of claims 10 to 12, which is a fruit juice, fruit drink, flavored water, soda, sports drink, kombucha-based beverage, yogurt-based beverage, tea-based beverage, or coffee-based beverage.
14. The heat-treated acidic probiotic beverage according to any one of claims 10 to 13, wherein the Bacillus subtilis spores are derived from Bacillus subtilis HU58 (trademark) (Bacillus subtilis having accession number EF101709) and / or Bacillus subtilis DE111 (registered trademark) (Bacillus subtilis having accession number NRRL B-67989).
15. A heat-treated acidic probiotic beverage according to any one of claims 10 to 14, comprising viable spores derived from at least one probiotic species other than Bacillus subtilis.
